SEC Filings

Filing date Description Form Filing Group View

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

A preliminary proxy statement providing notification matters to be brought to a vote

PRE 14A
Proxy Filings
View HTML

Initial filing by director officer or owner of more than ten percent

3
3,4,5
View HTML

Data provided by Kaleidoscope.

Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.